258 related articles for article (PubMed ID: 33021622)
1. Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease.
Trinder M; Uddin MM; Finneran P; Aragam KG; Natarajan P
JAMA Cardiol; 2020 Oct; 6(3):1-9. PubMed ID: 33021622
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program.
Vassy JL; Posner DC; Ho YL; Gagnon DR; Galloway A; Tanukonda V; Houghton SC; Madduri RK; McMahon BH; Tsao PS; Damrauer SM; O'Donnell CJ; Assimes TL; Casas JP; Gaziano JM; Pencina MJ; Sun YV; Cho K; Wilson PWF
JAMA Cardiol; 2023 Jun; 8(6):564-574. PubMed ID: 37133828
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis.
Patel J; Pallazola VA; Dudum R; Greenland P; McEvoy JW; Blumenthal RS; Virani SS; Miedema MD; Shea S; Yeboah J; Abbate A; Hundley WG; Karger AB; Tsai MY; Sathiyakumar V; Ogunmoroti O; Cushman M; Savji N; Liu K; Nasir K; Blaha MJ; Martin SS; Al Rifai M
JAMA Cardiol; 2021 Oct; 6(10):1161-1170. PubMed ID: 34259820
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis.
Kavousi M; Desai CS; Ayers C; Blumenthal RS; Budoff MJ; Mahabadi AA; Ikram MA; van der Lugt A; Hofman A; Erbel R; Khera A; Geisel MH; Jöckel KH; Lehmann N; Hoffmann U; O'Donnell CJ; Massaro JM; Liu K; Möhlenkamp S; Ning H; Franco OH; Greenland P
JAMA; 2016 Nov; 316(20):2126-2134. PubMed ID: 27846641
[TBL] [Abstract][Full Text] [Related]
5. Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies.
Yano Y; O'Donnell CJ; Kuller L; Kavousi M; Erbel R; Ning H; D'Agostino R; Newman AB; Nasir K; Hofman A; Lehmann N; Dhana K; Blankstein R; Hoffmann U; Möhlenkamp S; Massaro JM; Mahabadi AA; Lima JAC; Ikram MA; Jöckel KH; Franco OH; Liu K; Lloyd-Jones D; Greenland P
JAMA Cardiol; 2017 Sep; 2(9):986-994. PubMed ID: 28746709
[TBL] [Abstract][Full Text] [Related]
6. Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease: New Insights From a Large National Biobank.
Patel AP; Wang (汪敏先) M; Pirruccello JP; Ellinor PT; Ng K; Kathiresan S; Khera AV
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):465-474. PubMed ID: 33115266
[TBL] [Abstract][Full Text] [Related]
7. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index.
Khera R; Pandey A; Ayers CR; Carnethon MR; Greenland P; Ndumele CE; Nambi V; Seliger SL; Chaves PHM; Safford MM; Cushman M; Xanthakis V; Vasan RS; Mentz RJ; Correa A; Lloyd-Jones DM; Berry JD; de Lemos JA; Neeland IJ
JAMA Netw Open; 2020 Oct; 3(10):e2023242. PubMed ID: 33119108
[TBL] [Abstract][Full Text] [Related]
8. Elevated lipoprotein(a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: A cohort study from the UK Biobank.
Welsh P; Al Zabiby A; Byrne H; Benbow HR; Itani T; Farries G; Costa-Scharplatz M; Ferber P; Martin L; Brown R; Fonseca AF; Sattar N
Atherosclerosis; 2024 Feb; 389():117437. PubMed ID: 38219651
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.
Saeed A; Sun W; Agarwala A; Virani SS; Nambi V; Coresh J; Selvin E; Boerwinkle E; Jones PH; Ballantyne CM; Hoogeveen RC
Atherosclerosis; 2019 Mar; 282():52-56. PubMed ID: 30685442
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Risk Associated With Social Determinants of Health at Individual and Area Levels.
Xia M; An J; Safford MM; Colantonio LD; Sims M; Reynolds K; Moran AE; Zhang Y
JAMA Netw Open; 2024 Apr; 7(4):e248584. PubMed ID: 38669015
[TBL] [Abstract][Full Text] [Related]
11. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
[TBL] [Abstract][Full Text] [Related]
12. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.
Quispe R; Michos ED; Martin SS; Puri R; Toth PP; Al Suwaidi J; Banach M; Virani SS; Blumenthal RS; Jones SR; Elshazly MB
J Am Heart Assoc; 2020 Feb; 9(3):e013600. PubMed ID: 32013698
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events.
Helgason H; Eiriksdottir T; Ulfarsson MO; Choudhary A; Lund SH; Ivarsdottir EV; Hjorleifsson Eldjarn G; Einarsson G; Ferkingstad E; Moore KHS; Honarpour N; Liu T; Wang H; Hucko T; Sabatine MS; Morrow DA; Giugliano RP; Ostrowski SR; Pedersen OB; Bundgaard H; Erikstrup C; Arnar DO; Thorgeirsson G; Masson G; Magnusson OT; Saemundsdottir J; Gretarsdottir S; Steinthorsdottir V; Thorleifsson G; Helgadottir A; Sulem P; Thorsteinsdottir U; Holm H; Gudbjartsson D; Stefansson K
JAMA; 2023 Aug; 330(8):725-735. PubMed ID: 37606673
[TBL] [Abstract][Full Text] [Related]
14. Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease.
Ajufo E; Ayers CR; Vigen R; Joshi PH; Rohatgi A; de Lemos JA; Khera A
JAMA Cardiol; 2021 Feb; 6(2):179-187. PubMed ID: 33112372
[TBL] [Abstract][Full Text] [Related]
15. Determinants of incident atherosclerotic cardiovascular disease events among individuals with type 2 diabetic microvascular complications in the UK: a prospective cohort study.
Wang Y; Bulloch G; Huang Y; Liang Y; Du Z; Wu G; Fang Y; Hu Y; Shang X; Zhu Z; Zhang X; Yang X; Yu H
Diabetol Metab Syndr; 2023 Aug; 15(1):178. PubMed ID: 37644580
[TBL] [Abstract][Full Text] [Related]
16. Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention.
Marston NA; Pirruccello JP; Melloni GEM; Koyama S; Kamanu FK; Weng LC; Roselli C; Kamatani Y; Komuro I; Aragam KG; Butterworth AS; Ito K; Lubitz SA; Ellinor PT; Sabatine MS; Ruff CT
JAMA Cardiol; 2023 Feb; 8(2):130-137. PubMed ID: 36576811
[TBL] [Abstract][Full Text] [Related]
17. Implications of Social Disadvantage Score in Cardiovascular Outcomes and Risk Assessment: Findings From the Multi-Ethnic Study of Atherosclerosis.
Hammoud A; Chen H; Ivanov A; Yeboah J; Nasir K; Cainzos-Achirica M; Bertoni A; Khan SU; Blaha M; Herrington D; Shapiro MD
Circ Cardiovasc Qual Outcomes; 2023 Jul; 16(7):e009304. PubMed ID: 37403692
[TBL] [Abstract][Full Text] [Related]
18. Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study.
Patel AP; Wang M; Kartoun U; Ng K; Khera AV
Circulation; 2021 Aug; 144(6):410-422. PubMed ID: 34247495
[TBL] [Abstract][Full Text] [Related]
19. Association between lipoprotein(a), LPA genetic risk score, aortic valve disease, and subsequent major adverse cardiovascular events.
Moore MK; Jones GT; McCormick S; Williams MJA; Coffey S
Eur J Prev Cardiol; 2024 Apr; ():. PubMed ID: 38593219
[TBL] [Abstract][Full Text] [Related]
20. A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals.
Krarup NT; Borglykke A; Allin KH; Sandholt CH; Justesen JM; Andersson EA; Grarup N; Jørgensen T; Pedersen O; Hansen T
Atherosclerosis; 2015 Jun; 240(2):305-10. PubMed ID: 25864160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
